ASF/SF2 is a human protein previously shown to function in in vitro pre-mRNA splicing as an essential factor necessary for all splices and also as an alternative splicing factor, capable of switching selection of 5' splice sites. To begin to study the protein's mechanism of action, we have investigated the RNA binding properties of purified recombinant ASF/SF2. Using UV crosslinking and gel shift assays, we demonstrate that the RNA binding region of ASF/SF2 can interact with RNA in a sequence-specific manner, recognizing the 5' splice site in each of two different pre-mRNAs. Point mutations in the 5' splice site consensus can reduce binding by as much as a factor of 100, with the largest effects observed in competition assays. These findings support a model in which ASF/SF2 aids in the recognition of pre-mRNA 5' splice sites.
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Pre-mRNA splicing is a complex reaction that requires small nuclear ribonucleoprotein particles (snRNPs) and a large number of non-snRNP proteins (reviewed in refs. 1 and 2).
While the four snRNPs U1, U2, U4/U6, and U5 have been well characterized (3, 4) , much less is known about splicing proteins. In yeast, where introns are infrequent and alternative splicing is rare or nonexistent, a combination of genetic and biochemical approaches has led to the identification and characterization of a large number of non-snRNP proteins that are essential for splicing (reviewed in refs. 5 and 6). In higher eukaryotes, splicing proteins have been identified and characterized to date solely by biochemical assays. The sequences of about a half dozen of these proteins are known, and almost all contain one or more copy of the RNA recognition motif (7) or RNP-type RNA binding domain (RBD; see ref. 8 ). The RBD is an =80-amino acid domain found in a number of RNA binding proteins. It was first identified in poly(A) binding protein (9, 10) , and one or more copies have since been found in many RNA binding proteins (reviewed in refs. 11 and 12) . In several cases, RNA binding by these proteins has been shown to be sequence-specific, and it appears that different RBDs can recognize different RNA sequences and structures. The structures of two different RBDs have been determined (13) (14) (15) , and each consists ofa four-stranded antiparallel ,/sheet and two a-helices.
This arrangement places the two most highly conserved elements ofthe RBD, designated RNP-1 and RNP-2, adjacent to each other in the center of the 3-sheet.
Several RBD-containing proteins have been shown to be essential for pre-mRNA splicing in vitro. U2AF65 is an essential splicing factor that is required for U2 snRNP binding to the branch site region and that binds with specificity to the polypyrimidine tract of the 3' splice site (ss) (16) . U2AF65 contains three regions that share sequence similarity to the RBD consensus, which are all required for sequencespecific binding (17) . ASF/SF2, also an essential splicing factor, is required for a very early step in spliceosome assembly (18, 19) and contains two RBD-type sequences (20) (21) (22) . SC-35 is similar in structure to ASF/SF2 (23) and is also essential for an early step in spliceosome assembly (24) . Finally, several RBD-containing proteins have been shown, like U2AF, to bind with specificity to the polypyrimidine tract 3' ss (25) (26) (27) (28) (29) (30) .
ASF/SF2 has a second activity in vitro, which is that it can modulate selection of alternative splice sites in a concentration-dependent manner (31, 32) . Most frequently this results in a switch such that the 5' ss most proximal to the 3' ss is utilized almost exclusively at high concentrations of ASF/ SF2 (33) . These observations have led to the suggestion that one mechanism for modulating splice site selection in vivo might be to vary the concentration or activity of general splicing factors such as ASF/SF2. In this regard, it is noteworthy that the primary structure of ASF/SF2 shares similarity with known regulators of alternative splicing from Drosophila. Two of these proteins, Sex lethal (34) and Transformer-2 (35, 36) , contain RBDs and each can bind specifically to target pre-mRNAs (37, 38) . In addition, several of these regulators, including ASF/SF2, contain regions rich in repeats of arginine-serine dipeptides (RS domains).
An important goal in understanding how ASF/SF2 functions, as both an essential and an alternative splicing factor, is to understand how it interacts with RNA. Here we present data that ASF/SF2 binds specifically to pre-mRNA fragments containing an intact 5' ss.
MATERIALS AND METHODS DNA Plasmids. The simian virus 40 (SV40) small t introncontaining fragment, from the plasmid pHd (39) , was inserted into the HindIII-Pst I sites of pGem in the orientation of the SP6 promoter, producing pGt. All pGt derivatives contain 11 nucleotides (nts) from the pGem3 vector at their 5' end. Mutants 50-511 were made by in vitro mutagenesis of pGt using appropriate oligonucleotides. Mutant t31 was made with an oligonucleotide that introduced a 5-base change at the 3' ss of the small t intron. The 5' ss mutant tA5 was derived from mutant 51, resulting in deletion of sequences upstream of position +4 relative to the 5' ss. The 3' ss deletion mutant tA3 was made by deleting sequences downstream from position -4 relative to the 3' ss of pGt. The pGe plasmid containing the wild-type (wt) 13S intron of Ela was constructed by inserting a 230-bp fragment from the adenovirus Ela gene (33) into the HindIII-Xba I sites of pGem. The mutant pGe5l, containing 4 base changes at the 5' ss of the 13S intron, was constructed from pGe.
RNA and Protein Preparations. In vitro run-off transcription was performed with SP6 polymerase (unless indicated) as described (31) . To were included in synthesis reactions. Transcripts were purified on denaturing polyacrylamide gels. Expression and purification of ASF/SF2 proteins in Escherichia coli were as described (20) . Protein concentrations were determined by the Bradford method, and proteins were monitored by Coomassie blue staining of SDS/polyacrylamide gels.
RNA Binding Assays. The same RNA binding buffer was used for UV crosslinking and gel shift assays and contained 10 mM Hepes (pH 7.9), 200 mM KC1, 20 mM NaCl, 0.025% Nonidet P-40, 1 mM dithiothreitol, 15 pg of bovine serum albumin per ml, and 10%o glycerol. For UV crosslinking, 1-3 x 104 cpm (10-50 fmol) of each RNA was added per 25-tl reaction mixture, which also contained S ug of tRNA (and unlabeled competitor RNA where indicated). Twenty to 200 pmol ofpurified recombinant protein (see figure legends) was incubated with RNA in binding buffer for 20 min at room temperature, and the RNA-protein complexes were irradiated at a distance of 6 cm with a hand-held mineral light (model UVG-11; 254 nm) for 10 min. Ten micrograms of RNase A was added and the samples were incubated for 30 min at 30'C. An equal volume of 2 x SDS gel loading buffer was added to each sample, and aliquots were analyzed by electrophoresis through an SDS/15% polyacrylamide gel. Gel shift assays were performed with smaller amounts of 32P-labeled RNA (1-5 fmol). One to 400 pmol of ASF/SF2 derivatives as indicated and 5 ,ug of tRNA (plus unlabeled competitor where indicated) were added to 25-gl reaction mixtures prior to addition of the labeled probes. Samples were incubated for 30 min at room temperature and analyzed on 6% polyacrylamide (acrylamide:bisacrylamide ratio, 40:1) gels. Gels were electrophoresed in 0.5 x TBE buffer at 3.5 W for 4 hr.
RESULTS
Our previous studies showed that ASF/SF2 can influence splicing of SV40 early (20, 31) and adenovirus Ela (33) pre-mRNAs. The protein activated splicing of each RNA when added to extracts lacking ASF/SF2 and favored use of the downstream most 5' ss in each. To determine whether this activity might reflect sequence-specific binding of ASF/SF2, we first performed a series of UV crosslinking experiments with purified HeLa cell ASF/SF2 and RNA fragments spanning the entire early SV40 transcript used in the splicing experiments. The results indicated that the strongest crosslinking occurred to an 100-nt RNA encompassing the 66-nt small t intron (H. Ge and J.L.M., unpublished data). Here we have examined binding to a similar fragment, using recombinant ASF/SF2. In most experiments, an ASF/SF2 mutant, ASFARS, was used (22) . This derivative lacks 50 C-terminal residues, which correspond almost precisely to the RS domain. A similar region in U2AF65 has been shown to increase affinity but reduce sequence-specific RNA binding in vitro (17) , and a similar situation occurred with ASF/ SF2 (result not shown).
ASFARS UV Crosslinks Preferentiafly to 5' ss-Containing RNAs. We first tested the ability of ASFARS to crosslink to each of four different 32P-labeled RNA transcripts (see Fig.   1E ). One (t intron) was a 95-nt RNA that spanned the entire small t intron. A second (13S) contained the Ela 13S 5' ss, but not the 3' ss, in a 125-nt transcript. pGEM and sk were similarly sized (104 and 115 nt) transcripts of plasmid sequences. Identical concentrations of each were incubated with equal amounts of ASFARS, UV irradiated, treated with RNase A, and subjected to SDS/polyacrylamide gel electrophoresis. Fig. 1A shows that significant crosslinking of the small t RNA to ASFARS occurred. While the 13S RNA also crosslinked efficiently (albeit less well than small t), crosslinking of the two nonspecific RNAs was at most barely detectable. Fig. 1B (Fig. 2) show that removal of the 3' ss had at most a small effect on crosslinkcig. However, the deletion that removed the 5' ss (A 5') essentially eliminated crosslinking. Competition experiments analogous to those in Fig. 1 confirmed that the differences in crosslinking were in fact due to differences in binding (Fig. 2) 53 . In contrast, a mutation changing 5 nts at the 3' ss had no significant effect on binding (results not shown; see Table 1 ). We also tested the effects of 5' ss mutations on ASFARS binding in competition assays. For this, an amount of ASFARS sufficient to shift -50%o of the small t RNA was incubated with 32P-labeled wt RNA plus increasing amounts of the indicated unlabeled competitor RNAs (Fig. 4A) . As expected, the wt RNA functioned very effectively as a competitor, reducing binding to the labeled RNA significantly at even the lowest concentration of competitor, a 5-fold excess, and almost eliminating binding at the highest concentration (125-fold excess). In contrast, a nonspecific RNA (pGEM) and mutant 51 RNA were essentially inactive as competitors. Inefficient competition was also observed when the RNA containing the single base change at position +2 of the 5' ss (mutant 52) was used. Significant competition was detected only with the highest amount of competitor tested, indicating that at least 10-fold more 52 RNA was required to obtain competition comparable to that observed with the wt RNA. We also examined the ability of wt and mutant 52 RNAs to compete when mutant 52 RNA was used as the labeled substrate (Fig. 4B ). wt RNA was again an excellent competitor, greatly reducing binding of the labeled RNA at even the lowest concentration. When mutant 52 RNA was used as a competitor, binding of the labeled RNA was also reduced, although significantly less effectively than with wt RNA. Together these results strongly suggest that the 5' ss is critical for efficient binding of ASFARS to the small t RNA.
To extend this analysis, we examined a number of additional 5' ss mutations, using the competition assay shown in Fig. 4 . Specifically, we determined the ability of unlabeled mutant RNAs to compete with 32P-labeled wt small t RNA in gel shift assays and compared this with the amount of unlabeled wt RNA required to achieve a similar level of competition. The results obtained are presented in Table 1 A Fig. 3 , except that the indicated competitors were mixed with the radiolabeled RNA prior to incubation with ASFARS (20 pmol and allow several conclusions. The first addresses the question ofwhether a perfect 5' ss consensus might be the optimal target for binding. While the small t site is an exceptionally strong match to consensus, it is not perfect (8/9; see Fig. 3 ). Mutant 50 contains a perfect consensus, changing the A to a G at position +5. The behavior of this RNA as a competitor was nearly identical to that of wt, indicating that a perfect consensus is not a better binding site. Second, single base changes at positions + 1 through +4 all had significant effects on competition (mutants 510, 52, 57, and 55). The largest effect (15-fold) was seen with a G to C change at +1. In addition, if one assumes that the effects of individual mutations are at most multiplicative, then it can be concluded that a G to U change at position -1 also has a substantial effect on competition (compare mutants 51, 52, and 55 ). An important question regarding ASF/SF2 function concerns its ability to select one 5' ss over another. For example, our previous experiments established a very strong preference for the small t 5' ss relative to the large T site (20, 31) . The results presented here raise the possibility that this may reflect, at least in part, a differential affinity of ASF/SF2 for the two 5' ss. To address this, we constructed a derivative of the small t RNA in which the small t ss, from -3 to +6, was replaced with the large T 5' ss. When this "large T" RNA was used in the competition assay, it was still active as a competitor, but was =7-fold less efficient than small t RNA (mutant 511; see Table 1 ). These findings are consistent with a role for ASF/SF2 affinity in selection of alternative splice sites.
EFcient Binding of ASFARS to Adenovirus Ela Pre-mRNA Also Requires an Intact 5' ss. To test whether ASFARS could bind another pre-mRNA in a 5' ss-dependent manner, we used the adenovirus Ela pre-mRNA fragment that was employed in the crosslinking experiments described above. Binding of ASFARS to the wt RNA and to a mutant containing four base changes in the 5' ss was examined using gel shift and UV crosslinking assays. Consistent with the crosslinking experiment in Fig. 1 , the Ela RNA (wt 13S) was shifted less efficiently than was the SV40 RNA (Fig. SA) . However, as with the small t RNA, the 5' ss mutant bound 5-to 10-fold less well. In the UV crosslinking assay (Fig. SB) , the wt RNA interacted significantly more strongly with ASFARS than did the mutant RNA. Again, as with the SV40 RNA, even more striking effects of the 5' ss mutation were observed under conditions of competition: Increasing concentrations of unlabeled wt RNA greatly reduced crosslinking of the labeled RNA, while the same concentrations of mutant RNA were essentially without effect.
DISCUSSION
The above data provide strong evidence that ASF/SF2 can specifically recognize pre-mRNA 5' ss, making it, to our knowledge, the only protein splicing factor capable of recognizing a 5' ss. Given that ASF/SF2 is an essential splicing factor and, importantly, also able to influence 5' ss selection, this interaction is almost certainly functionally significant. Previous studies are consistent with recognition of the 5' ss by a factor other than U1 snRNP. First, the original suppression experiments that proved the base-pairing interaction between Ul snRNA and the 5' ss also revealed that not all 5' ss mutations tested could be suppressed (40) . This finding suggested that these nonsuppressible bases might serve a function in splicing other than pairing with Ul snRNA, and our results are consistent with the idea that this could be binding of ASF/SF2. Second, UV crosslinking experiments employing nuclear extracts identified an -35-kDa protein whose crosslinking to pre-mRNA depended on an intact 5' ss and which was approximately the size of ASF/SF2 (41).
Proc. Nod. Acad Sci. USA 91 (1994) Finally, in the Drosophila P element 5' exon, a multiprotein complex has been shown to bind a 5' ss-like sequence (42 5 ' ss has been detected in nuclear extracts, although its identity was not determined (43) . In addition, our recent experiments have detected direct interactions between ASF/SF2 and Ul snRNP that likely contribute to 5' ss recognition (44) . U5 (45) and U6 (46) snRNPs have also been shown to crosslink to pre-mRNAs near the 5' ss. Although these interactions both appear to require ASF/SF2 activity, they may occur subsequent to ASF/SF2's role in splicing.
With respect to the role of ASF/SF2 in alternative 5' ss selection, a simple model can be presented. At low concentrations, ASF/SF2 preferentially binds to and activates the 5' ss with the highest affinity for the protein. At higher concentrations, additional 5' ss could be recognized and activated, and under these conditions we suggest that the 5' ss closest to the 3' ss will be preferentially utilized, due simply to its proximal location. By this model, distal sites of equal on lesser affinity for ASF/SF2 would not be used if ASF/SF2 was the sole determining factor. In such cases, we suggest that an additional factor(s) is required for use of the upstream sites. Indeed, two proteins capable of activating distal 5' ss in vitro have been described (47, 48 Tacke and J.L.M., unpublished data). Given that 5' ss are themselves generally purine rich (the small t site contains 7 of 9 purines), it'could be that certain 5' ss are targets for ASF/SF2 binding because they fit a purine-rich consensus. ASF/SF2 could then function in splicing by binding either at or near the 5' ss to be activated or, perhaps in the case of low-affinity 5' ss, at a distant site in the pre-mRNA.
Although ASF/SF2 is, to our knowledge, the only protein that can recognize 5' ss, there are likely to be others. The strongest candidates are additional members of the SR protein family, which is a conserved group of proteins that share structural similarities and that appear to have related activities in vitro (50, 51) . However, significant variations in the behavior of these proteins have recently been detected (52) (53) (54) (55) . It will be of interest to determine if the RNA binding specificity of other SR proteins is similar to that of ASF/SF2.
